Tisch MS News

Read the full press release on Dr. Sadiq's invitation to present at the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture. Vatican Stem Cell Conference Release

April 5, 2013

More

Listen to Dr. Sadiq's interview on 1010 WINS about the research he will present at the International Adult Stem Cell Conference at the Vatican this week!

April 9, 2013

More

Earlier this morning, Dr. Saud Sadiq presented his stem cell research to the attendees of the Second International Adult Stem Cell Conference held at the Vatican. Dr. Sadiq discussed the growing need for cellular therapy to be approved and used to repair the damage caused by multiple sclerosis...

April 12, 2013

More

Read the full press release on Dr. Sadiq's invitation to present at the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture. Vatican Stem Cell Conference Release

April 5, 2013

More

Several scientists and physicians from the Tisch MS Research Center of New York and affiliated International Multiple Sclerosis Management Practice attended the 65 th American Academy of Neurology (AAN) Annual Meeting in San Diego, CA from March 16-23, 2013. Drs. Armistead Williams, Violaine Harris...

April 3, 2013

More

Four posters by Tisch MS scientists were accepted by the American Academy of Neurology for presentation at the Academy's annual conference, held March 16-23 in San Diego, CA. The posters presented at AAN 2013 are: L.H. Bell, V.K. Harris, and S.A. Sadiq. "Identification of CSF biomarkers of...

March 27, 2013

More

TISCH MS RESEARCH CENTER OF NEW YORK ANNOUNCED Leading Research Center for Multiple Sclerosis Takes Name of Benefactors New York, NY- February 26, 2013 - The Board of Directors of the Multiple Sclerosis Research Center of New York (MSRCNY) today announced the re-naming of the institution as the...

February 26, 2013

More

Deirdre Dulak (Tisch MSRCNY) presented the following article in Journal Club. Article Title: Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis Reference: R.J. Fox, D.H. Miller, J.T. Phillips, M. Hutchinson, E. Havrdova, M. Kita, M. Yang, K. Raghupathi, M. Novas, M.T...

May 3, 2013

More

Dr. Sadiq has arrived in Rome and is preparing for tomorrow's presentation. Click on the link to view the entire conference schedule for Regenerative Medicine: A Fundamental Shift in Science and Culture http://adultstemcellconference.org/the-conference/conference-schedule/

April 10, 2013

More

The stem cell research division of the Tisch MS Research Center of New York proudly announces Food and Drug Administration (FDA) approval of autologous, mesenchymal stem cell-derived neural progenitor cells (MSC-NPs) as an Investigational New Drug (IND) for an open label, phase I clinical trial in...

August 14, 2013

More

Pages

News Archive

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Look for the IFF Building on the North side of 57th Street across from the CBS building

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.